Herpetic gingivostomatitis is a condition that most often results from initial gingiva (gums) and oral mucosa infection with herpes simplex virus type 1 (HSV-1). While herpetic gingivostomatitis is the most common cause of gingivostomatitis in children before the age of 5, it can also occur in adults. The condition is characterized by a prodrome of fever followed by an eruption of painful, ulcerative lesions of the gingiva and mucosa, and often, yellow, perioral, vesicular lesions. HSV-1 is usually spread from direct contact or via droplets of oral secretions or lesions from an asymptomatic or symptomatic individual. Once a patient is infected with the herpes simplex virus, the infection can recur in the form of herpes labialis with intermittent re-activation occurring throughout life.
Two, double-stranded DNA viruses of the Herpesviridae family, HSV-1 and HSV-2, are known to cause primary and recurrent herpetic gingivostomatitis. HSV-1 is mostly responsible for oral, ocular, and facial infections, while HSV-2 results primarily in herpetic lesions of the genital and cutaneous lower body. While most cases of herpetic gingivostomatitis are associated with HSV-1 infection, cases have been reported, mostly in older patients, of HSV-2 isolation. Oral infection with HSV-2 is probably transmitted through orogenital contact and has also been observed in HIV-positive patients and those on immunosuppressive therapy.
Primary herpetic gingivostomatitis typically occurs in children younger than the age of 5, but can also occur in adolescents and adults. It is estimated that almost 90% of the world’s population is seropositive for HSV-1 by age 35, and half of the individuals carrying the virus will experience reactivation in the form of herpes labialis. Herpetic gingivostomatitis is equally distributed amongst gender and race groups and is not found to have a particular seasonal or geographic distribution.,
The pathogenesis of herpetic gingivostomatitis involves replication of the herpes simplex virus, cell lysis, and eventual destruction of mucosal tissue. Exposure to HSV-1 at abraded surfaces allows the virus to enter and rapidly replicate in epidermal and dermal cells. This results in the clinical manifestation of perioral blisters, erosions of the lips and mucosa, and eventual hemorrhagic crusting. Sufficient viral inoculation and replication allow the virus to enter sensory and autonomic ganglia, where it travels intra-axonally to the ganglionic nerve bodies. HSV-1 most commonly infects the trigeminal ganglia, where the virus remains latent until reactivation most commonly in the form of herpes labialis.
Histological appearance of a mucosal herpetic infection includes degeneration of stratified squamous epithelium cells, acantholysis, and formation of an inflammatory infiltrate around the capillaries of the dermis. The characteristic intranuclear inclusion bodies known as Cowdry type A are found on light microscopy showing arrays of viral capsids and electron dense glycoproteins. Cowdry type A bodies are eosinophilic inclusion bodies that are also found in varicella-zoster, making the histologic lesions of herpetic gingivostomatitis and varicella indistinguishable. Direct immunohistochemistry using fluorescent antibodies can be used to further distinguish between the herpes virus and the varicella virus.
The initial sign of herpetic gingivostomatitis is inflammation of the oral and perioral mucosa, followed by rapidly spreading ulcerative and vesicular lesions on the gingiva, palate, buccal, and labial mucosa. The ulcerative lesions eventually rupture and become flat, yellow lesions with a red, pseudomembrane ranging from 2 to 5 mm in size. The ulcers are described as painful, quick to bleed, and typically heal without scarring in 2 to 3 weeks. Associated symptoms of herpetic gingivostomatitis include a prodrome of fever, anorexia, irritability, and lymphadenitis primarily in the cervical and submandibular region.
The diagnosis of herpetic gingivostomatitis is usually clinical, based on the appearance of perioral and oral ulcers. However, if additional testing is required, herpetic gingivostomatitis can be confirmed diagnostically using a direct immunofluorescent examination of ulcer scrapings or blister fluid. Another test that can be used but is not entirely diagnostically reliable is the Tzanck smear. The Tzanck smear will confirm the presence of a virus in active lesions but fails to distinguish between HSV-1, HSV-2, and varicella-zoster virus.
The most important component in the management of herpetic gingivostomatitis is hydration. Adequate hydration is often achieved with pain control; thus, analgesics such as oral acetaminophen and oral rinses are encouraged to make the patient more comfortable and promote fluid intake. It is important to note that patients who are unable to drink to maintain proper hydration should be hospitalized. Other indications for hospitalization include immunocompromised children, patients who develop eczema herpeticum, and HSV spread that results in encephalitis or pneumonitis.
Immunocompetent patients with significant pain or refusal to drink can be administered oral acyclovir if they present within 96 hours of disease onset. Studies show that administration of oral acyclovir within 96 hours of disease onset can result in reduced viral shedding, early resolution of lesions, and improvement in eating difficulties. Immunocompromised patients with herpetic gingivostomatitis can benefit from intravenous (IV) acyclovir to shorten the duration of symptoms and lesions. In patients with acyclovir-resistant herpetic gingivostomatitis, foscarnet 80 to 120 mg per kg per day is the recommended drug.
Barrier lip creams such as petroleum jelly have been suggested to prevent adhesions in patients with active herpetic gingivostomatitis.
Without perioral and oral lesions, the diagnosis of herpetic gingivostomatitis can often be overlooked. In the pediatric population, the child’s decreased appetite can be attributed to changes in diet or teething. Despite the largely based clinical diagnosis of herpetic gingivostomatitis, it is important first to rule out other diseases that present similarly, keeping in mind the age group and past medical history of the patient. Some of the differential diagnoses to keep in mind when considering herpetic gingivostomatitis include:
Herpes gingivostomatitis is best managed by an interprofessional team that includes the primary care provider, nurse practitioner, emergency department physician and infectious disease expert. Because of the pain, many patients are not able to eat or drink. In sich cases, admission is recommended for IV hydration. If an antiviral is started, it should be given within 24 hours of symptoms to be effective. Delayed dosing is not only expensive but futile.
Most patients do recover without any treatment but unfortunately, recurrences are common.
|||Tovaru S,Parlatescu I,Tovaru M,Cionca L, Primary herpetic gingivostomatitis in children and adults. Quintessence international (Berlin, Germany : 1985). 2009 Feb [PubMed PMID: 19169443]|
|||Arduino PG,Porter SR, Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features. Journal of oral pathology [PubMed PMID: 18197856]|
|||George AK,Anil S, Acute herpetic gingivostomatitis associated with herpes simplex virus 2: report of a case. Journal of international oral health : JIOH. 2014 Jun [PubMed PMID: 25083042]|
|||Taieb A,Body S,Astar I,du Pasquier P,Maleville J, Clinical epidemiology of symptomatic primary herpetic infection in children. A study of 50 cases. Acta paediatrica Scandinavica. 1987 Jan [PubMed PMID: 3031926]|
|||Cataldo F,Violante M,Maltese I,Traverso G,Paternostro D, [Herpetic gingivostomatitis in children: the clinico-epidemiological aspects and findings with acyclovir treatment. A report of the cases of 162 patients]. La Pediatria medica e chirurgica : Medical and surgical pediatrics. 1993 Mar-Apr [PubMed PMID: 8321723]|
|||Leinweber B,Kerl H,Cerroni L, Histopathologic features of cutaneous herpes virus infections (herpes simplex, herpes varicella/zoster): a broad spectrum of presentations with common pseudolymphomatous aspects. The American journal of surgical pathology. 2006 Jan [PubMed PMID: 16330942]|
|||Mohan RP,Verma S,Singh U,Agarwal N, Acute primary herpetic gingivostomatitis. BMJ case reports. 2013 Jul 8 [PubMed PMID: 23839615]|
|||Yarom N,Buchner A,Dayan D, Herpes simplex virus infection: part I--Biology, clinical presentation and latency. Refu'at ha-peh veha-shinayim (1993). 2005 Jan [PubMed PMID: 15786655]|
|||Mortazavi H,Safi Y,Baharvand M,Rahmani S, Diagnostic Features of Common Oral Ulcerative Lesions: An Updated Decision Tree. International journal of dentistry. 2016 [PubMed PMID: 27781066]|
|||Faden H, Management of primary herpetic gingivostomatitis in young children. Pediatric emergency care. 2006 Apr [PubMed PMID: 16651921]|
|||Amir J,Harel L,Smetana Z,Varsano I, Treatment of herpes simplex gingivostomatitis with aciclovir in children: a randomised double blind placebo controlled study. BMJ (Clinical research ed.). 1997 Jun 21 [PubMed PMID: 9224082]|
|||Goldman RD, Acyclovir for herpetic gingivostomatitis in children. Canadian family physician Medecin de famille canadien. 2016 May [PubMed PMID: 27255621]|
|||Sciubba JJ, Herpes simplex and aphthous ulcerations: presentation, diagnosis and management--an update. General dentistry. 2003 Nov-Dec [PubMed PMID: 15055647]|
|||Amir J,Harel L,Smetana Z,Varsano I, The natural history of primary herpes simplex type 1 gingivostomatitis in children. Pediatric dermatology. 1999 Jul-Aug [PubMed PMID: 10469407]|
|||Tamay Z,Ozcekert D,Onel M,Agacfidan A,Guler N, A child presenting with primary gingivostomatitis and eczema herpeticum. Minerva pediatrica. 2016 Feb [PubMed PMID: 26864720]|